Hikma is set to add strength to its portfolio with an acquisition that marks its expansion into Canada. The company is acquiring the Canadian assets of Teligent for $45.75 million. The transaction ...

Feb 22 (Reuters) - British drugmaker Hikma Pharmaceuticals (HIK.L), opens new tab reported a bigger-than-expected profit for 2023 on Thursday, helped by a strong performance of its generics ...

Hikma is introducing cefazolin for injection in dosage strengths of 2 g and 3 g. The drug treats certain infections caused by bacteria including skin, bone, joint, genital, blood, the lining of ...

AMMAN — S&P has announced on 8 May that it has raised its long-term issuer credit rating on Hikma Pharmaceuticals PLC (Hikma) and its $500 million notes outstanding due on July 9, 2025 ...

In a new antitrust suit, generics maker Hikma has accused Amarin of “deliberately and meticulously” locking up the supply icosapent ethyl in an attempt to block generic competition.

Hikma Pharmaceuticals reported a strong financial performance for 2024, with revenue rising nine per cent to $3.13bn (£2.47bn) and operating profit up 67 per cent to $612m (£483m). Profit ...

(Reuters) - Generic drugmaker Hikma Pharmaceuticals USA Inc has sued Amarin Pharma Inc, accusing it of using illegal tactics to delay generic competition for its heart drug Vascepa. In a complaint ...

The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another copy of the ...

BOSTON, Feb 1 (Reuters) - A division of French advertising company Publicis Groupe SA (PUBP.PA), opens new tab and drug company Hikma Pharmaceuticals (HIK.L), opens new tab have reached separate ...

After Hikma initiated a recall of one batch of acetaminophen injection earlier this month, the company is extending the nationwide recall to the consumer level. The company started the recall (PDF ...

Hikma Pharmaceuticals (OTCPK:HKMPF) announced on Thursday that it has acquired the FDA-approved Abbreviated New Drug Application (ANDA) for trametinib tablets, a cancer treatment medication, from ...